Natalizumab alters the TCR repertoire after one year of treatment in four MS patients

Laure Michel; Marion Salou; Alexandra Garcia; Nicolas Degauque; Anne Salmon; Annie Elong Ngono; Arnaud Nicot; Sandrine Wiertlewski; Jean-Paul Soulillou; Sophie Brouard; David Laplaud

Conference papers

Natalizumab alters the TCR repertoire after one year of treatment in four MS patients

Laure Michel ^{1, 2} Marion Salou ¹ Alexandra Garcia ¹ Nicolas Degauque ¹ Anne Salmon ¹ Annie Elong Ngono ¹ Arnaud Nicot ¹ Sandrine Wiertlewski ² Jean-Paul Soulillou ¹ Sophie Brouard ¹ David Laplaud ^{1, 2}

1 Immunointervention dans les allo et xénotransplantations

2 Service de neurologie [Nantes]

Résumé : n.a

Document type :

Conference papers

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadata

https://www.hal.inserm.fr/inserm-00643971
Contributor : Ed. BMC Connect in order to contact the contributor
Submitted on : Wednesday, November 23, 2011 - 1:08:13 PM
Last modification on : Wednesday, April 27, 2022 - 3:50:03 AM
Long-term archiving on: : Friday, February 24, 2012 - 2:28:50 AM

Natalizumab alters the TCR repertoire after one year of treatment in four MS patients

Files

Identifiers

Collections

Citation

Export

Metrics

45

162

Natalizumab alters the TCR repertoire after one year of treatment in four MS patients

Files

Identifiers

Collections

Citation

Export

Share

Metrics

45

162